-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics issues Series A and B warrants for 1,363,638 shares in registered direct offering at $3.3 each

PUBT·06/11/2026 12:02:01
Listen to the news
Atossa Therapeutics issues Series A and B warrants for 1,363,638 shares in registered direct offering at $3.3 each
  • Atossa Therapeutics launched a registered direct offering with 1,363,638 shares bundled with Series A warrants and short-term Series B warrants.
  • Combined offering price USD 3.3 per share; warrants exercise at USD 4.4, exercisable six months from issuance.
  • Series A warrants expire 5.5 years from issuance; Series B warrants expire in 2 years; closing expected June 12, 2026.
  • Net proceeds expected at about USD 4.1 million; potential additional gross proceeds of about USD 12 million if warrants are exercised.
  • No plan to list the Series Warrants on Nasdaq or any other trading venue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-266717), on June 11, 2026, and is solely responsible for the information contained therein.